ENTITY
Grifols

Grifols (GRFS US)

16
Analysis
Health CareSpain
Grifols S.A. develops, manufactures, and markets plasma derivatives, IV Therapy, enteral nutrition, diagnostic systems, and medical materials.
more
bullishGrifols
08 Oct 2024 10:41Syndicated

Grifols A/B Spread (GRF.P) - Monday, Jul 8, 2024

A/B shares were issued in 2011 as part of an acquisition, allowing Grifols to expand its presence in the biopharmaceutical sector while maintaining...

Logo
180 Views
Share
bullishGrifols
19 Aug 2024 17:48

Liquid Universe of European Ordinary and Preferred Shares: August‘24 Report

Since mid-July, share-price spreads have generally widened across our European liquid universe of ordinary and preferred shares (9 have tightened,...

Share
04 Nov 2024 09:00

Active Merger Arbitrage and Litigation Opportunities: Key Insights on Current Financial Market

Learning Technologies Group and TI Fluid Systems are engaged in merger arbitrage, with due diligence and PUSU deadlines approaching.

04 Nov 2024 09:00

SSI Weekly Newsletter: October Performance, Portfolio Updates, and Key Developments

SSI Tracking Portfolio decreased by 3.1% in October but is up 6.6% year-to-date, with detailed stock performance breakdown available.

bullishGrifols
18 Jul 2024 19:44

Liquid Universe of European Ordinary and Preferred Shares: July‘24 Report

Since mid-June, share-price spreads have generally tightened across our European liquid universe of ordinary and preferred shares (13 have...

Share
x